Quantum BioPharma Financials
| QNTM Stock | 4.51 0.03 0.66% |
The essential information of the day-to-day investment outlook for Quantum BioPharma includes many different criteria found on its balance sheet. An individual investor should monitor Quantum BioPharma's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Quantum BioPharma.
Net Income |
|
Quantum | Select Account or Indicator |
Quantum BioPharma Stock Summary
Quantum BioPharma competes with Columbia Sportswear, Hudson Pacific, Vera Bradley, Douglas Emmett, and Levi Strauss. Quantum BioPharma is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 35954B206 35954B404 74764Y205 |
| Older Symbol | HUGE |
| Location | Ontario; Canada |
| Business Address | 55 University Ave, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.quantumbiopharma.com |
Quantum BioPharma Key Financial Ratios
| Net Income | (17.9 M) | ||||
| Total Asset | 17.47 M | ||||
| Retained Earnings | (157.91 M) |
Quantum BioPharma Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Income | (35.5M) | (32.3M) | (38.3M) | (17.9M) | (20.6M) | (21.6M) | |
| End Period Cash Flow | 17.5M | 35.3M | 17.0M | 2.8M | 2.5M | 2.4M |
Quantum Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quantum BioPharma's current stock value. Our valuation model uses many indicators to compare Quantum BioPharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quantum BioPharma competition to find correlations between indicators driving Quantum BioPharma's intrinsic value. More Info.Quantum BioPharma is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Quantum BioPharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Quantum BioPharma Systematic Risk
Quantum BioPharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Quantum BioPharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Quantum BioPharma correlated with the market. If Beta is less than 0 Quantum BioPharma generally moves in the opposite direction as compared to the market. If Quantum BioPharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Quantum BioPharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Quantum BioPharma is generally in the same direction as the market. If Beta > 1 Quantum BioPharma moves generally in the same direction as, but more than the movement of the benchmark.
Quantum BioPharma March 14, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Quantum BioPharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Quantum BioPharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Quantum BioPharma based on widely used predictive technical indicators. In general, we focus on analyzing Quantum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Quantum BioPharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.36 | |||
| Information Ratio | 0.0747 | |||
| Maximum Drawdown | 132.94 | |||
| Value At Risk | (14.38) | |||
| Potential Upside | 17.3 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.